Filed: 5/15/2026ACC: 0001104659-26-062467
📋 What this filing means
FORESITE CAPITAL MANAGEMENT VI LLC filed this quarterly 13F‑HR report disclosing 17 equity positions with a total reported market value of $460.27M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
17
Positions
$460.27M
Total AUM (reported)
22.71M
Total Shares
Allocation by class
COM$384.50M83.5%
SPONSORED ADS$54.18M11.8%
CL A$11.18M2.4%
COM CL A$5.99M1.3%
ORD$4.44M1.0%
Portfolio Concentration
Top 3$298.10M64.8%
4–10$118.64M25.8%
11–25$43.53M9.5%
Top 3 weight
64.8%
Top 10 weight
90.5%
Voting Authority Distribution
Total shares with voting rights: 22.71M
Sole
Full voting authority
22.71M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole17
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings17
Rows:
CG Oncology, Inc.
SOLEShares2.22M
TypeSH
Market value$150.35M
32.67%
Sole
2.22M
Shared
0.00
None
0.00
ALUMIS INC.
SOLEShares4.25M
TypeSH
Market value$93.58M
20.33%
Sole
4.25M
Shared
0.00
None
0.00
Centessa Pharmaceuticals plc
SOLEShares1.36M
TypeSH
Market value$54.18M
11.77%
Sole
1.36M
Shared
0.00
None
0.00
Corvus Pharmaceuticals, Inc.
SOLEShares1.83M
TypeSH
Market value$26.79M
5.82%
Sole
1.83M
Shared
0.00
None
0.00
Denali Therapeutics Inc.
SOLEShares1.21M
TypeSH
Market value$23.23M
5.05%
Sole
1.21M
Shared
0.00
None
0.00
AGIOS PHARMACEUTICALS, INC.
SOLEShares525K
TypeSH
Market value$17.76M
3.86%
Sole
525K
Shared
0.00
None
0.00
Verastem, Inc.
SOLEShares3.15M
TypeSH
Market value$16.68M
3.62%
Sole
3.15M
Shared
0.00
None
0.00
Kymera Therapeutics, Inc.
SOLEShares146.33K
TypeSH
Market value$12.19M
2.65%
Sole
146.33K
Shared
0.00
None
0.00
Minerva Neurosciences, Inc.
SOLEShares1.99M
TypeSH
Market value$11.97M
2.60%
Sole
1.99M
Shared
0.00
None
0.00
Celldex Therapeutics, Inc.
SOLEShares315.91K
TypeSH
Market value$10.02M
2.18%
Sole
315.91K
Shared
0.00
None
0.00
AtaiBeckley Inc.
SOLEShares2.75M
TypeSH
Market value$9.73M
2.12%
Sole
2.75M
Shared
0.00
None
0.00
Hinge Health, Inc.
SOLEShares220.40K
TypeSH
Market value$8.50M
1.85%
Sole
220.40K
Shared
0.00
None
0.00
Crinetics Pharmaceuticals, Inc.
SOLEShares212.01K
TypeSH
Market value$7.70M
1.67%
Sole
212.01K
Shared
0.00
None
0.00
OnKure Therapeutics, Inc.
SOLEShares1.45M
TypeSH
Market value$5.99M
1.30%
Sole
1.45M
Shared
0.00
None
0.00
Jade Biosciences, Inc.
SOLEShares320K
TypeSH
Market value$4.50M
0.98%
Sole
320K
Shared
0.00
None
0.00
GH Research PLC
SOLEShares315.49K
TypeSH
Market value$4.44M
0.96%
Sole
315.49K
Shared
0.00
None
0.00
Zura Bio Ltd
SOLEShares450K
TypeSH
Market value$2.68M
0.58%
Sole
450K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
CG Oncology, Inc.SOLE | COM | 2.22M | SH | $150.35M 32.67% | 2.22M | 0.00 | 0.00 |
ALUMIS INC.SOLE | COM | 4.25M | SH | $93.58M 20.33% | 4.25M | 0.00 | 0.00 |
Centessa Pharmaceuticals plcSOLE | SPONSORED ADS | 1.36M | SH | $54.18M 11.77% | 1.36M | 0.00 | 0.00 |
Corvus Pharmaceuticals, Inc.SOLE | COM | 1.83M | SH | $26.79M 5.82% | 1.83M | 0.00 | 0.00 |
Denali Therapeutics Inc.SOLE | COM | 1.21M | SH | $23.23M 5.05% | 1.21M | 0.00 | 0.00 |
AGIOS PHARMACEUTICALS, INC.SOLE | COM | 525K | SH | $17.76M 3.86% | 525K | 0.00 | 0.00 |
Verastem, Inc.SOLE | COM | 3.15M | SH | $16.68M 3.62% | 3.15M | 0.00 | 0.00 |
Kymera Therapeutics, Inc.SOLE | COM | 146.33K | SH | $12.19M 2.65% | 146.33K | 0.00 | 0.00 |
Minerva Neurosciences, Inc.SOLE | COM | 1.99M | SH | $11.97M 2.60% | 1.99M | 0.00 | 0.00 |
Celldex Therapeutics, Inc.SOLE | COM | 315.91K | SH | $10.02M 2.18% | 315.91K | 0.00 | 0.00 |
AtaiBeckley Inc.SOLE | COM | 2.75M | SH | $9.73M 2.12% | 2.75M | 0.00 | 0.00 |
Hinge Health, Inc.SOLE | CL A | 220.40K | SH | $8.50M 1.85% | 220.40K | 0.00 | 0.00 |
Crinetics Pharmaceuticals, Inc.SOLE | COM | 212.01K | SH | $7.70M 1.67% | 212.01K | 0.00 | 0.00 |
OnKure Therapeutics, Inc.SOLE | COM CL A | 1.45M | SH | $5.99M 1.30% | 1.45M | 0.00 | 0.00 |
Jade Biosciences, Inc.SOLE | COM | 320K | SH | $4.50M 0.98% | 320K | 0.00 | 0.00 |
GH Research PLCSOLE | ORD | 315.49K | SH | $4.44M 0.96% | 315.49K | 0.00 | 0.00 |
Zura Bio LtdSOLE | CL A | 450K | SH | $2.68M 0.58% | 450K | 0.00 | 0.00 |